Abstract
Between March 9, 1984 and January 29, 1992, 42 children with newlydiagnosed symptomatic or previously diagnosed progressive low-gradegliomas received outpatient chemotherapy as their primary treatment.This study was a single arm, phase II trial designed to estimate the time to tumor progression and toxicity of this regimen. Procarbazine, 6-thioguanine, and dibromodulcitolwere given before lomustine (CCNU) and vincristine was given 1and 3 weeks after CCNU. Patients were treated for six treatmentcycles or until the tumor progressed, whichever came first. Twenty-three patients had juvenile pilocytic astrocytomas, 11had astrocytomas, one had oligodendroglioma, one had ganglioglioma, and six had radiographically diagnosed low-grade gliomas. The mean age of the patients was 5 years (median, 3 years). The median time to treatment failure was 132 weeks (95% confidence interval:106, 186 weeks). Only eight patients have died; the estimated 5-yearsurvival rate is 78% (95% confidenceinterval, 60% 87%). There were two episodes of grade 4 neutropenia, and three episodes of grade 4 thrombocytopenia. Thisregimen was safe, able to be delivered in the outpatient setting, andproduced prolonged periods of disease stabilization in children with low-grade gliomas.
Similar content being viewed by others
References
Gilles F: The Childhood Brain Tumor Consortium: A study of childhood brain tumors based on surgical biopsies from ten North American institutions. J Neurooncol 6: 9–23, 1988
Rodriguez LA, Edwards MSB, Levin VA: Management of hypothalamic gliomas in children: An analysis of 33 cases. Neurosurgery 26: 242–246, 1990
Duffner PK, Cohen ME, Thomas PRM, Lansky SB: The long-term effects of cranial irradiation on the central nervous system. Cancer 56: 1841–1846, 1985 (suppl 7)
Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 23: 79–85, 1988
Friedman HS, Krischer JP, Burger P, Oaks WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH Jr: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 10: 249–256, 1992
Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN, Phillips PC, Ryan J, Boyett JM, Geyer R, Finlay J: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11: 850–856, 1993
Pons A, Finlay JL, Walker RW: Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurol Oncol 14: 151–158, 1992
Fujimoto S, Ogawa M, Sakurai Y: Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1-2-chloroethyl)-1-nitrosourea hydrochloride. Cancer Res 42: 4079–4085, 1982
Bodell WJ, Morgan WF, Williams ME, Deen DF: Potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Biochem Pharmacol 34: 515–520, 1985
Hunter KJ, Deen DF, Marton LJ: Differential response to 1,3-bis(2-chloroethyl)-1-nitrosourea in drug-resistant and-sensitive 9L rat brain tumor cells pretreated with ?-difluoromethylornithine and 6-thioguanine. Int J Cancer 44: 658–660, 1989
Weinkam RJ, Shiba DA: Metabolic activation of procarbazine. Life Sci 22: 937–945, 1978
Zlotogorski C, Erickson LC: Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosourea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosourea alone. Carcinogenesis 4: 759–763, 1983
Institoris E: DNA alkylation sites and cytotoxicity in Yoshida cells treated with bifunctional galactitols. In: Petri P, Grassi GG (eds) Current Chemotherapy and Immunotherapy, American Society of Microbiology, Washington DC 1378–1380, 1982
Lapis K, Jeney A, Kopper L, Szende B, Takacs J: Theoretical basis for designing combination therapy with dibromodulcitol (DBD). In: Hellman K, Connors TA (eds) Cancer Chemotherapy, Plenum Press, New York 37–42, 1976
Levin VA, Wilson CB: Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens. Cancer Chemother Pharmacol 1: 41–48, 1978
Petronio J, Edwards MSB, Prados M, Freyberger S, Rabbit J, Silver P, Levin VA: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701–708, 1991
Levin VA, Crafts DC, Norman DM, Hoffer PB, Spine J-P, Wilson CB: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47: 329–335, 1977
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prados, M.D., Edwards, M.S., Rabbitt, J. et al. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 32, 235–241 (1997). https://doi.org/10.1023/A:1005736104205
Issue Date:
DOI: https://doi.org/10.1023/A:1005736104205